The platelet-rich plasma market is expected to register a CAGR of 12.1% during the forecast period. The market value is projected to increase from US$ 594 million in 2024 to US$ 1.8 billion by 2034. The market for platelet-rich plasma recorded a growth of 10.0% in 2023.
Platelet-rich Plasma Market Size, Analysis, and Insights
Attributes | Details |
---|---|
Market Size, 2024 | US$ 594 million |
Market Value, 2034 | US$ 1.8 billion |
Value CAGR (2024 to 2034) | 12.1% |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Aside from the platelet-rich plasma market, the section analyzed reports on two other related industries: the platelet function test market and the cosmetic surgery products market.
Platelet-rich Plasma Market:
Attributes | Platelet-rich Plasma Market |
---|---|
Value-based CAGR (2024 to 2034) | 12.1% |
Market Trends | Increasing adoption of regenerative medicine |
Growth Opportunities | surging demand for platelet-rich plasma therapy in the cosmetic industry for facial rejuvenation and hair restoration |
Platelet Function Test Market:
Attributes | Platelet Function Test Market |
---|---|
Value-based CAGR (2024 to 2034) | 6.3% |
Market Trends | Growing prevalence of platelet abnormalities, injuries, and illness |
Growth Opportunities | Increasing awareness toward platelet, growing chronic diseases, and rising sports injuries |
Cosmetic Surgery Products Market:
Attributes | Cosmetic Surgery Products Market |
---|---|
Value-based CAGR (2024 to 2034) | 8.2% |
Market Trends | Growing awareness toward cosmetic procedures, fat-freezing technology, and non-invasive procedures |
Growth Opportunities | Rising novel cosmetic treatments and expanding cosmetic and personal care industry |
Attributes | Details |
---|---|
Product Type | Pure Platelet-rich Fibrin (P-PRF) |
Market Share in 2024 | 42.1% |
Attributes | Details |
---|---|
Origin Type | Autologous Platelet-rich Plasma |
Market Share in 2024 | 86.2% |
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Countries | CAGR through 2024 to 2034 |
---|---|
United States | 10.9% |
Germany | 10.3% |
China | 11.7% |
United Kingdom | 12.4% |
Japan | 13.0% |
There are several established players in the regenerative medicine industry, and with growing demand for effective procedures with fewer side effects, new entrants are trying to establish their presence in the market. Numerous companies offer a range of products and services related to platelet-rich plasma, including kits, devices, and services for preparing and applying platelet-rich plasma. However, due to rising chronic diseases and increasing competition, companies must focus on research and development and advance their product portfolio to differentiate themselves in the market.
Recent Developments
China is estimated to hold a share of 11.7% share in 2024.
The market is currently valued at around US$ 594 million.
The pure-platelet-rich plasma (P-PRP) segment held 42.1% of the market share in 2024.
The United States accounts for around 10.9% of the share in 2024.
The global market is set to reach a valuation of around US$ 1.8 billion by the end of 2034.
Demand for the platelet-rich plasma increased at a 10% CAGR from 2019 to 2023.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034 4.1. Historical Market Size Value (US$ Million) Analysis, 2019 to 2023 4.2. Current and Future Market Size Value (US$ Million) Projections, 2024 to 2034 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2019 to 2023 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2024 to 2034 5.3.1. Pure-(P-PRP) 5.3.2. Leukocyte-(L-PRP) 5.3.3. Leukocyte-Platelet-Rich Fibrin (L-PRF) 5.4. Y-o-Y Growth Trend Analysis By Product Type, 2019 to 2023 5.5. Absolute $ Opportunity Analysis By Product Type, 2024 to 2034 6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Origin Type 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Origin Type, 2019 to 2023 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Origin Type, 2024 to 2034 6.3.1. Autologous 6.3.2. Homologous 6.3.3. Allogenic 6.4. Y-o-Y Growth Trend Analysis By Origin Type, 2019 to 2023 6.5. Absolute $ Opportunity Analysis By Origin Type, 2024 to 2034 7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application Type 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application Type , 2019 to 2023 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application Type , 2024 to 2034 7.3.1. Orthopaedic Surgery 7.3.2. Cosmetic Surgery 7.3.3. General Surgery 7.3.4. Neurosurgery 7.3.5. Other Surgeries (Urological, Cardiothoracic, Periodontal, and Oral and Maxillofacial) 7.4. Y-o-Y Growth Trend Analysis By Application Type , 2019 to 2023 7.5. Absolute $ Opportunity Analysis By Application Type , 2024 to 2034 8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2019 to 2023 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2024 to 2034 8.3.1. North America 8.3.2. Latin America 8.3.3. Western Europe 8.3.4. Eastern Europe 8.3.5. South Asia and Pacific 8.3.6. East Asia 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Product Type 9.2.3. By Origin Type 9.2.4. By Application Type 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Product Type 9.3.3. By Origin Type 9.3.4. By Application Type 9.4. Key Takeaways 10. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Product Type 10.2.3. By Origin Type 10.2.4. By Application Type 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Product Type 10.3.3. By Origin Type 10.3.4. By Application Type 10.4. Key Takeaways 11. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. UK 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Western Europe 11.2.2. By Product Type 11.2.3. By Origin Type 11.2.4. By Application Type 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Product Type 11.3.3. By Origin Type 11.3.4. By Application Type 11.4. Key Takeaways 12. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 12.2.1. By Country 12.2.1.1. Poland 12.2.1.2. Russia 12.2.1.3. Czech Republic 12.2.1.4. Romania 12.2.1.5. Rest of Eastern Europe 12.2.2. By Product Type 12.2.3. By Origin Type 12.2.4. By Application Type 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Product Type 12.3.3. By Origin Type 12.3.4. By Application Type 12.4. Key Takeaways 13. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Bangladesh 13.2.1.3. Australia 13.2.1.4. New Zealand 13.2.1.5. Rest of South Asia and Pacific 13.2.2. By Product Type 13.2.3. By Origin Type 13.2.4. By Application Type 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Product Type 13.3.3. By Origin Type 13.3.4. By Application Type 13.4. Key Takeaways 14. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 14.2.1. By Country 14.2.1.1. China 14.2.1.2. Japan 14.2.1.3. South Korea 14.2.2. By Product Type 14.2.3. By Origin Type 14.2.4. By Application Type 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Product Type 14.3.3. By Origin Type 14.3.4. By Application Type 14.4. Key Takeaways 15. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2019 to 2023 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2024 to 2034 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Product Type 15.2.3. By Origin Type 15.2.4. By Application Type 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Product Type 15.3.3. By Origin Type 15.3.4. By Application Type 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2023 16.1.2.1. By Product Type 16.1.2.2. By Origin Type 16.1.2.3. By Application Type 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2023 16.2.2.1. By Product Type 16.2.2.2. By Origin Type 16.2.2.3. By Application Type 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2023 16.3.2.1. By Product Type 16.3.2.2. By Origin Type 16.3.2.3. By Application Type 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2023 16.4.2.1. By Product Type 16.4.2.2. By Origin Type 16.4.2.3. By Application Type 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2023 16.5.2.1. By Product Type 16.5.2.2. By Origin Type 16.5.2.3. By Application Type 16.6. UK 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2023 16.6.2.1. By Product Type 16.6.2.2. By Origin Type 16.6.2.3. By Application Type 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2023 16.7.2.1. By Product Type 16.7.2.2. By Origin Type 16.7.2.3. By Application Type 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2023 16.8.2.1. By Product Type 16.8.2.2. By Origin Type 16.8.2.3. By Application Type 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2023 16.9.2.1. By Product Type 16.9.2.2. By Origin Type 16.9.2.3. By Application Type 16.10. Poland 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2023 16.10.2.1. By Product Type 16.10.2.2. By Origin Type 16.10.2.3. By Application Type 16.11. Russia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2023 16.11.2.1. By Product Type 16.11.2.2. By Origin Type 16.11.2.3. By Application Type 16.12. Czech Republic 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2023 16.12.2.1. By Product Type 16.12.2.2. By Origin Type 16.12.2.3. By Application Type 16.13. Romania 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2023 16.13.2.1. By Product Type 16.13.2.2. By Origin Type 16.13.2.3. By Application Type 16.14. India 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2023 16.14.2.1. By Product Type 16.14.2.2. By Origin Type 16.14.2.3. By Application Type 16.15. Bangladesh 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2023 16.15.2.1. By Product Type 16.15.2.2. By Origin Type 16.15.2.3. By Application Type 16.16. Australia 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2023 16.16.2.1. By Product Type 16.16.2.2. By Origin Type 16.16.2.3. By Application Type 16.17. New Zealand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2023 16.17.2.1. By Product Type 16.17.2.2. By Origin Type 16.17.2.3. By Application Type 16.18. China 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2023 16.18.2.1. By Product Type 16.18.2.2. By Origin Type 16.18.2.3. By Application Type 16.19. Japan 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2023 16.19.2.1. By Product Type 16.19.2.2. By Origin Type 16.19.2.3. By Application Type 16.20. South Korea 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2023 16.20.2.1. By Product Type 16.20.2.2. By Origin Type 16.20.2.3. By Application Type 16.21. GCC Countries 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2023 16.21.2.1. By Product Type 16.21.2.2. By Origin Type 16.21.2.3. By Application Type 16.22. South Africa 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2023 16.22.2.1. By Product Type 16.22.2.2. By Origin Type 16.22.2.3. By Application Type 16.23. Israel 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2023 16.23.2.1. By Product Type 16.23.2.2. By Origin Type 16.23.2.3. By Application Type 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Product Type 17.3.3. By Origin Type 17.3.4. By Application Type 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Harvest Technologies Corp. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Zimmer Biomet Holdings Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Arthrex, Inc. 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Arteriocyte Medical Systems, Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Dr. PRP America 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Cesca Therapeutics, Inc. 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Regen Lab SA. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Johnson & Johnson Services, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. Stryker 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Apex Biologix 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports